SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
Nov 16, 2015
Document Date
Nov 12, 2015
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
ReShape Lifesciences
Issuer
Filer
GLADNEY DAN W
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE